A.CabunaganR
For GLP-1 therapies, pairing dosing with lived experience is how we move from short-term wins to durable impact, safer titration, and measurable value in the real world
Semaglutide Versus Liraglutide and Placebo for Weight Loss in Patients with Type 2 Diabetes (SUSTAIN 7): A Randomized, Double-Blind, Phase 3 Trial
At Yunique Medical , well work with you to design a treatment plan that aligns with your unique health goals
Punitive damages may be awarded in cases where it can be shown that the manufacturer of Ozempic, Novo Nordisk, knew the risk of harm associated with using the drug and failed to warn consumers, putting profits over patients
Neurological symptoms like tingling or numbness could take several weeks or months of consistent treatment to improve